Cargando…
Tumour Suppressive Function and Modulation of Programmed Cell Death 4 (PDCD4) in Ovarian Cancer
BACKGROUND: Programmed cell death 4 (PDCD4), originally identified as the neoplastic transformation inhibitor, was attenuated in various cancer types. Our previous study demonstrated a continuous down-regulation of PDCD4 expression in the sequence of normal-borderline-malignant ovarian tissue sample...
Autores principales: | Wei, Na, Liu, Stephanie S., Chan, Karen K. L., Ngan, Hextan Y. S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3260274/ https://www.ncbi.nlm.nih.gov/pubmed/22272332 http://dx.doi.org/10.1371/journal.pone.0030311 |
Ejemplares similares
-
Loss of Programmed cell death 4 (Pdcd4) associates with the progression of ovarian cancer
por: Wei, Na, et al.
Publicado: (2009) -
Programmed cell death 4 (PDCD4) suppresses metastastic potential of human hepatocellular carcinoma cells
por: Zhang, Shuhong, et al.
Publicado: (2009) -
The role of tumour suppressor PDCD4 in beta cell death in hypoxia
por: Kumar, Sandeep, et al.
Publicado: (2017) -
Programmed cell death 4 (PDCD4) expression during multistep Barrett's carcinogenesis
por: Fassan, Matteo, et al.
Publicado: (2010) -
Programmed cell death 4 (PDCD4) as a novel prognostic marker for papillary thyroid carcinoma
por: Galuppini, Francesca, et al.
Publicado: (2019)